Lunai Bioworks (LNAI) Convertible Debt (2016 - 2026)

Lunai Bioworks (LNAI) recorded quarterly Convertible Debt of $120000.0 in Q1 2026, down 87.74% quarter-over-quarter from $978495.0 in Q4 2025.

Lunai Bioworks (LNAI) Convertible Debt (2016 - 2026) Analysis & Trends

Lunai Bioworks' Convertible Debt history runs 9 years deep, the most recent figure standing at $120000.0 for Q1 2026.

  • In Q1 2026, Convertible Debt changed N/A year-over-year to $120000.0; the TTM figure through Mar 2026 stood at $120000.0 (changed N/A YoY), while the FY2025 annual figure was $245000.0, changed 0.0% from the prior year.
  • Convertible Debt was $120000.0 for Q1 2026 at Lunai Bioworks, down from $978495.0 in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $3.7 million in Q1 2024 to a low of $120000.0 in Q1 2026.
  • Historically, Convertible Debt has averaged $1.1 million across 5 years, with a median of $1.2 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Convertible Debt tumbled 37.27% in 2023, then soared 208.39% in 2024.
  • A 5-year view of Convertible Debt shows it stood at $1.2 million in 2022, then surged by 114.11% to $2.6 million in 2023, then tumbled by 90.46% to $245000.0 in 2024, then soared by 299.39% to $978495.0 in 2025, then sank by 87.74% to $120000.0 in 2026.
  • The last three Convertible Debt figures came in at $120000.0 (Q1 2026), $978495.0 (Q4 2025), and $245000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Lunai Bioworks 95.85 Mn 92.70 Mn 20,942.00

Historic Data

Download Data
DateValue
Mar 31, 2026 120,000.00
Dec 31, 2025 978,495.00
Sep 30, 2025 245,000.00
Jun 30, 2025 245,000.00
Jun 30, 2024 245,000.00
Mar 31, 2024 3.70 Mn
Dec 31, 2023 2.57 Mn
Sep 30, 2023 752,741.00
Mar 31, 2023 1.20 Mn
Dec 31, 2022 1.20 Mn
Sep 30, 2022 1.20 Mn
Jun 30, 2022 1.20 Mn
Mar 31, 2022 1.20 Mn
Dec 31, 2021 1.20 Mn
Sep 30, 2021 1.20 Mn
Jun 30, 2021 1.20 Mn
Mar 31, 2021 1.20 Mn
Dec 31, 2020 1.20 Mn
Sep 30, 2020 1.20 Mn
Jun 30, 2020 1.20 Mn